Impact of belantamab mafodotin vs pomalidomide/low-dose dexamethasone treatment on health-related quality of life and vision-related functioning in patients with relapsed/refractory multiple myeloma

被引：0
|
作者：
Dimopoulos, Meletios [1 ]
Weisel, Katja [2 ]
Hungria, Vania [3 ]
Sapra, Sandhya [4 ]
Sule, Neal [4 ]
Li, Mary [4 ]
McKeown, Astrid [5 ]
Kazeem, Gbenga [5 ]
Polinkovsky, Margaret [6 ]
Meunier, Juliette [7 ]
Loubert, Angely [7 ]
Bunod, Laurine [7 ]
Perera, Sue [8 ]
Currie, Brooke [9 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Athens, Greece
[2] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[3] Clin Sao Germano, Dept Hematol, Sao Paulo, Brazil
[4] GSK, Upper Providence, PA USA
[5] GSK, Stevenage, Herts, England
[6] GSK, Durham, NC USA
[7] Modus Outcomes, Lyon, France
[8] GSK, London, England
[9] GSK, Rockville, MD USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-252
引用
收藏
页码：S174 / S175
页数：2
相关论文
共 50 条
  • [41] Comparison of Health-Related and Vision-Related Quality of Life in a Low Vision Patient Sample
    Malkin, A.
    Goldstein, J.
    Massof, R. W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [42] Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States
    Shah, Anshul
    Tosh, Jonathan C.
    Ambavane, Apoorva
    Nikolaou, Andreas
    Hogea, Cosmina
    Samyshkin, Yevgeniy
    Gorsh, Boris
    Maiese, Eric M.
    Wang, Feng
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 789 - 800
  • [43] Health-related quality of life outcomes in relapsed and/or refractory multiple myeloma: a systematic review
    Sparano, Francesco
    Cavo, Michele
    Niscola, Pasquale
    Efficace, Fabio
    QUALITY OF LIFE RESEARCH, 2016, 25 : 123 - 124
  • [44] Matching-adjusted indirect comparison of talquetamab vs selinexor-dexamethasone and vs belantamab mafodotin in patients with relapsed/refractory multiple myeloma
    Reece, Donna
    Diels, Joris
    Van Sanden, Suzy
    Pei, Lixia
    Ammann, Eric
    Heuck, Christoph
    Kane, Colleen
    Londhe, Anil
    Peterson, Steve
    Chari, Ajai
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (10) : 1769 - 1783
  • [45] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Outcomes Based on Prior Treatment Exposure
    Vij, Ravi
    Hofmeister, Craig C.
    Richardson, Paul G.
    Jagannath, Sundar
    Siegel, David S.
    Baz, Rachid
    Chen, Min
    Zaki, Mohamed
    Larkins, Gail
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (21)
  • [46] Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma
    Wang, Chunling
    He, Zhengmei
    Shi, Yuye
    Zhang, Lijuan
    Chen, Yue
    Chen, Zhi
    Yu, Liang
    HEMATOLOGY, 2017, 22 (02) : 88 - 92
  • [47] Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-Related Quality of Life for Patients with Relapsed/Refractory Multiple Myeloma ( RRMM): Final Data from the Phase 2 ELOQUENT-3 Trial
    Weisel, Katja
    Dimopoulos, Meletios A.
    San-Miguel, Jesus
    Paner, Agne
    Engelhardt, Monika
    Taylor, Fiona
    Lord-Bessen, Jennifer
    Yao, David
    Yip, Christine
    Greenwood, Mike
    Tang, Jackson
    Cavo, Michele
    BLOOD, 2021, 138
  • [48] Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma
    Siegel, David
    Weisel, Katja
    Zahlten-Kumeli, Anita
    Medhekar, Rohan
    Ding, Bifeng
    Leleu, Xavier
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 3002 - 3010
  • [49] DREAMM-8: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B- Pd) Vs Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Trudel, Suzanne
    Davis, Randy
    Lewis, Nicole M.
    Bakshi, Kalpana K.
    Chopra, Bikramjit
    de Oca, Rocio Montes
    Ferron-Brady, Geraldine
    Eliason, Laurie
    Kremer, Brandon E.
    Gupta, Ira
    Wu, Frank S.
    BLOOD, 2020, 136
  • [50] LONGITUDINAL COMPARISON OF PATIENTS' AND PHYSICIANS' PERCEPTIONS OF PATIENTS' HEALTH-RELATED QUALITY OF LIFE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Vande Broek, I.
    Petrucci, M. T.
    Leleu, X.
    Murphy, P.
    Welslau, M.
    Bacon, P.
    Lewis, P.
    Gilet, H.
    Arnould, B.
    Kyriakou, C.
    HAEMATOLOGICA, 2014, 99 : 368 - 368
12345